Search
for
Sort by
Research 661–690 of 1000+
- Amphiregulin in Fibrotic Diseases and Cancer
- Eyelash trichomegaly complicating pembrolizumab for colorectal cancer
- Raman spectroscopy reveals biophysical markers in skin cancer surgical margins
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Comparison of Efficacy and Specificity in Cancer‐Targeting Prodrug Conjugates
- 3D analysis of facial morphology in Dutch children with cancer
- THERAPEUTIC ASPECTS OF ONION IN TREATMENT OF CANCER AND RELATED ISSUES: A REVIEW
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- Management of Alopecia Due to Cancer Therapies
- Association of melanoma and nonmelanoma skin cancer with antihypertensive drugs: A report from the Research on Adverse Drug events And Reports project
- Androgen receptor-mediated gene activation in prostate cancer cells
- Terapia antiandrogénica como quimioprevención del cáncer de próstata
- A Cross-Sectional Study on Symptom Burden, Malnutrition Risk, Psychological Distress and Palliative Outcomes in Cancer Patients Undergoing Chemotherapy
- Quality and Readability of Online Skin Cancer Patient Education Materials: A Cross-Sectional Study
- Psychosocial Effect of Appearance Changes Associated With Cancer: A Scoping Review
- Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Cold Atmospheric Plasma for Breast Cancer
- Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Association between Androgenic Hair Patterns and Prostate Cancer Risk in South Indian Men: A Case-control Study from the Cauvery Delta.
- Ayurveda-Based Supportive Care Using Guduchi, Ashwagandha, and Curcumin for Breast Cancer Patients: A Pilot Observational Study on Quality of Life and Safety
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Environmental factors influencing hormone receptor positive breast cancer incidence: integrating chemical signatures from dust wipes with self-reported sources of exposure
- Increased blood level of urea and creatinine after chemotherapy in breast cancer patients
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Dynamic changes of gut and skin microbiota in pancreatic cancer-induced skin injury